Krishi

Executive Summary

Krishi is a US-based diagnostics company developing novel, accessible testing solutions aimed at improving disease detection and patient management. Leveraging point-of-care and molecular diagnostics, the company seeks to address gaps in accurate and timely diagnosis, particularly in underserved settings. As a platform-stage startup, Krishi is positioned to disrupt traditional diagnostics through innovative technology. While early-stage and with limited public information, the company's focus on accessibility and accuracy aligns with growing demand for decentralized testing. Key risks include regulatory hurdles and competition from established players. However, if successful, Krishi could capture significant market share in the expanding point-of-care diagnostics space.

Upcoming Catalysts (preview)

• H2 2026Series A funding round70% success
• Q3 2026First product prototype announcement60% success
• Q4 2026Strategic partnership with healthcare provider50% success